Term ends Apr 20, 2032 · Low confidence
20-year base term ends Apr 20, 2032
Filed Mar 21, 2016 as application 15/076,536 · Granted Mar 19, 2019
Base term, 20 years from filing
Today
2012
2032
Clock starts
Apr 20, 2012
Apr 20, 2012
Term ends
Apr 20, 2032
Apr 20, 2032
Granted
Mar 19, 2019
Mar 19, 2019
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,321,842, to Apr 20, 2032. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 20, 2012, when application PCT/EP2012/001721, the earliest non-provisional in its chain, was filed (this one was filed Mar 21, 2016); a parent in its chain could not be resolved (the next row) | Apr 20, 2032 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,321,842) | resolves to Apr 20, 2032, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 14117118 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Apr 20, 2032 | Low confidence |
This family
| US 9,321,842 | In force Aug 2032 | Aug 2032 |
| US 10,233,253 | this patent Apr 2032 | Apr 2032 |
| US 10,919,974 | In force Apr 2032 | Apr 2032 |
| US 11,859,008 | In force Apr 2032 | Apr 2032 |
| Application 18/520,264 | Pending not computed | not computed |
5 of 6 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 4, 2017 Reel 42156, frame 574 | Sahin, Ugur; Türeci, Özlem; Koslowski, Michael; Walter, Korden; Wöll, Stefan; Hubner, Bernd; Erdeljan, Michael; Weichel, Michael; Kreuzberg, Maria | Ganymed Pharmaceuticals AG; Johannes Gutenberg-Universität Mainz | Assignment of Assignor's Interest |
| Apr 4, 2017 reel/frame not recorded | Sahin, Ugur; Weichel, Michael; Hubner, Bernd; Koslowski, Michael; Erdeljan, Michael; Kreuzberg, Maria; Türeci, Özlem; Walter, Korden; Wöll, Stefan | Ganymed Pharmaceuticals AG | Assignment of Assignor's Interest |
| Apr 4, 2017 reel/frame not recorded | Sahin, Ugur; Weichel, Michael; Hubner, Bernd; Koslowski, Michael; Erdeljan, Michael; Kreuzberg, Maria; Türeci, Özlem; Walter, Korden; Wöll, Stefan | Johannes Gutenberg-Universität Mainz | Assignment of Assignor's Interest |
| Sep 29, 2017 Reel 44061, frame 844 | Ganymed Pharmaceuticals AG | Ganymed Pharmaceuticals AG | Notice of Change in Assignee Address |
| Jul 7, 2020 Reel 53135, frame 922 | Ganymed Pharmaceuticals AG | Ganymed Pharmaceuticals GmbH | Change of Name |
| Aug 4, 2025 Reel 71926, frame 811 | Ganymed Pharmaceuticals GmbH | Astellas Pharma Inc. | Assignment of Assignor's Interest |
| Aug 4, 2025 Reel 72356, frame 929 | Ganymed Pharmaceuticals AG | Ganymed Pharmaceuticals GmbH | Change of Name |
| Nov 10, 2025 Reel 72847, frame 700 | Johannes Gutenberg-Universität Mainz | Tron - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg Universität Mainz GmbH | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Apr 2032
Term ends Apr 20, 2032. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 9,321,842, ends no earlier than this term, so it caps nothing.
Citations
11
later US patents cite this one
That is top 25% of utility patents granted in 2019 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.